Results for tag: "Systemic Sclerosis Drug"

Systemic Sclerosis (SSc) is a rare autoimmune disorder that affects the skin, joints, and internal organs. It is characterized by thickening and hardening of the skin, as well as inflammation and scarring of the internal organs. Treatment of SSc is largely symptomatic, and there are no approved drugs specifically for the condition. However, some drugs used to treat other conditions, such as central nervous system (CNS) drugs, may be used to manage symptoms of SSc. CNS drugs used to treat SSc include anticonvulsants, antidepressants, and muscle relaxants. These drugs are used to reduce pain, improve mobility, and reduce fatigue. They may also be used to treat depression, anxiety, and other psychological symptoms associated with SSc. The market for CNS drugs used to treat SSc is largely driven by the increasing prevalence of the condition. As the number of people diagnosed with SSc increases, so does the demand for CNS drugs. Some companies in the market include Pfizer, Novartis, and GlaxoSmithKline. These companies produce a variety of CNS drugs used to treat SSc, including anticonvulsants, antidepressants, and muscle relaxants. Show Less Read more